Baker Avenue Asset Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $427K | Sell |
13,143
-1
| -0% | -$33 | 0.01% | 322 |
|
|
2025
Q1 | $496K | Buy |
13,144
+1
| +0% | +$38 | 0.02% | 296 |
|
|
2024
Q4 | $1.08M | Hold |
13,143
| – | – | 0.03% | 228 |
|
|
2024
Q3 | $1.5M | Sell |
13,143
-500
| -4% | -$57.1K | 0.05% | 208 |
|
|
2024
Q2 | $1.03M | Hold |
13,643
| – | – | 0.04% | 220 |
|
|
2024
Q1 | $932K | Sell |
13,643
-137
| -1% | -$9.36K | 0.04% | 218 |
|
|
2023
Q4 | $865K | Hold |
13,780
| – | – | 0.04% | 218 |
|
|
2023
Q3 | $703K | Hold |
13,780
| – | – | 0.04% | 232 |
|
|
2023
Q2 | $688K | Hold |
13,780
| – | – | 0.03% | 225 |
|
|
2023
Q1 | $516K | Sell |
13,780
-30
| -0.2% | -$1.12K | 0.03% | 257 |
|
|
2022
Q4 | $662K | Buy |
13,810
+30
| +0.2% | +$1.44K | 0.04% | 213 |
|
|
2022
Q3 | $331K | Hold |
13,780
| – | – | 0.02% | 273 |
|
|
2022
Q2 | $300K | Hold |
13,780
| – | – | 0.02% | 264 |
|
|
2022
Q1 | $333K | Hold |
13,780
| – | – | 0.02% | 250 |
|
|
2021
Q4 | $328K | Buy |
+13,780
| New | +$328K | 0.02% | 253 |
|